医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

GC Labs and Affiliates Participate in IFCC WorldLab Seoul 2022 as a Platinum Sponsor

2022年06月16日 PM10:00
このエントリーをはてなブックマークに追加


 

YONGIN, South Korea

GC Labs today announced that GC Labs and its affiliates including GC Cell, GC MS and GC Genome will participate in the IFCC WorldLab 2022 as a platinum sponsor held on 26-30 June 2022 at Coex Convention & Exhibition Center in Seoul.

IFCC WorldLab Congress is the world’s most prestigious academic conference for the lab profession, attended by approximately 4,000 clinical chemistry and laboratory medicine experts from 100 countries to share the latest advances in clinical laboratory science and diagnostics technology.

These four organizations will host a highly interactive booth under the theme of ‘Journey to Healthy Life’. Designed to resemble the interior of an airport terminal, the booth will also consist of exciting “experience zones” offering: a virtual reality tour of a GC Labs laboratory using Matterport technology; an opportunity to experience GCare Lipid of GC MS, a personal in-vitro diagnostic product that can measure cholesterol, triglycerides and more, and receive test results.

In addition, they will hold an academic seminar to raise the importance of diagnostic tests on 27-28 June. The seminar will be composed of laboratory medicine evolving after Corona 19 pandemic; Artificial intelligence(AI)-based gene analysis technology; application of ADPS technology liquid biopsy & PCT(Procalcitonin) biopsy method.

“It is significant in that four organizations with their own specialized fields at each stage of the laboratory medicine process gather to create various synergies and introduce total healthcare services.” said Dr. Eun-hee Lee, President of GC Labs. “This congress will be a significant opportunity to share trends and outlooks on global laboratory medicine.”

About GC Labs

GC Labs is the South Korea’s leading clinical laboratory, a specialist in infectious diseases, and serves as part of the Global Diagnostics Network. GC Labs has enabled patients to receive accurate diagnoses and the right treatment with unrivaled quality of routine and specialized clinical tests. Around 800 employees at GC Labs offer more than 5,000 tests and test combinations, ranging from routine tests to highly esoteric molecular and genetic assays. With more than 40 years of accumulated know-how, GC Labs values the principles of providing the best treatment for patients even in unpredictable medical environments through passionate and ceaseless efforts. Not only domestically, but GC Labs has managed to expand overseas by entering a Lab Service Agreement with different areas of the world such as Sri Lanka, Vietnam, Myanmar, Indonesia, India, UAE, Jordan, Cambodia, Bahrain, Saudi Arabia and etc. GC Labs is qualified with excellent medical standard of medical manpower, level, infrastructure, and etc. For further information, please visit our official website

View source version on businesswire.com: https://www.businesswire.com/news/home/20220616005417/en/

CONTACT

Investor/Media Contact

Sean Hwang

seanhwang@gclabs.co.kr

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Cullgen Announces Chinese NMPA Allowance of Investigational New Drug Application of TRK Degrader to Begin Clinical Trials
  • 2023年扎耶德可持续发展奖持续彰显全球影响力,收获超4,500份申请
  • ザーイド・サステナビリティ賞2023年度の応募を締切り、最終応募数は4,500件超に!
  • U.S. Alliance Pharma Expands Early Phase Bioanalytical Services Into Australia
  • Avivagen Announces Receipt of Repeat Order from Asian Customer